Low heart rate variability and cancer-related fatigue in breast cancer survivors
Open accessThe DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
Cancer-related fatigue is a common and often long lasting symptom for many breast cancer survivors. Fatigued survivors show evidence of elevated inflammation, but the physiological mechanisms driving inflammatory activity have not been determined. Alterations in the autonomic nervous system, and particularly parasympathetic nervous system activity, are a plausible, yet understudied contributor to cancer-related fatigue. The goal of this study was to replicate one previous study showing an association between lower parasympathetic activity and higher fatigue in breast cancer survivors (Fagundes et al., 2011), and to examine whether inflammation mediates this association. Study participants were drawn from two samples and included 84 women originally diagnosed with early-stage breast cancer prior to age 50. Participants completed questionnaires, provided blood samples for determination of interleukin (IL)-6 and C-reactive protein (CRP), and underwent electrocardiography (ECG) assessment for evaluation of resting heart rate variability (HRV), a measure of parasympathetic activity. Results showed that lower HRV was associated with higher fatigue (p < .05), as predicted. In bivariate analyses, HRV was also correlated with circulating concentrations of IL-6 and CRP. However, path analyses did not support inflammation as a mediator of the association between HRV and fatigue; instead, associations among these variables appeared to be driven by age and BMI. These findings identify HRV as a potential contributor to cancer-related fatigue, but suggest that inflammation does not mediate this association in younger, healthy breast cancer survivors who are several years post-treatment. The autonomic nervous system merits additional attention in research on the etiology of cancer-related fatigue.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Heart Rate Variability: Standards of Measurement, Physiological Interpretation, and Clinical Use
Electrophysiology, T. F. O. T. E. S. O. C. T. N. A. (1996) · Circulation · doi:10.1161/01.cir.93.5.1043 · Cited by 17,159
Heart rate variability: Standards of measurement, physiological interpretation, and clinical use
Malik, M., Bigger, J. T., Camm, A. J., Kleiger, R. E., Malliani, A., Moss, A. J., & Schwartz, P. J. (1996) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a014868 · Cited by 15,289
Confidence Limits for the Indirect Effect: Distribution of the Product and Resampling Methods
MacKinnon, D. P., Lockwood, C. M., & Williams, J. (2004) · Multivariate Behavioral Research · doi:10.1207/s15327906mbr3901_4 · Cited by 7,806
Required sample size to detect the mediated effect
Fritz, M. S., & MacKinnon, D. P. (2007) · Psychological Science · doi:10.1111/j.1467-9280.2007.01882.x · Cited by 4,810
Tracey, K. J. (2002) · Nature · doi:10.1038/nature01321 · Cited by 3,728
Heart rate variability as an index of regulated emotional responding
Appelhans, B. M., & Luecken, L. J. (2006) · Review of General Psychology · doi:10.1037/1089-2680.10.3.229 · Cited by 1,893
Iacobucci, D., Saldanha, N., & Deng, X. (2007) · Journal of Consumer Psychology · doi:10.1016/s1057-7408(07)70020-7 · Cited by 1,362 · cited 1×
“Mediation is tested by evaluating the significance of the indirect effect, which is determined by comparing the total and direct effects (see Fig. 1; Iacobucci et al., 2007).”
BackgroundTracey, K. J. (2009) · Nature Reviews Immunology · doi:10.1038/nri2566 · Cited by 1,154
Fatigue in breast cancer survivors: occurrence, correlates, and impact on quality of life.
Bower, J. E., Ganz, P. A., Desmond, K. A., Rowland, J. H., Meyerowitz, B. E., & Belin, T. R. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.4.743 · Cited by 1,134 · cited 1×
“Cancer-related fatigue negatively impacts quality of life, and may predict shorter survival (Andrykowski et al., 1998; Bower et al., 2000; Groenvold et al., 2007).”
BackgroundSelf-citationReduced heart rate variability and mortality risk in an elderly cohort. The Framingham Heart Study
Tsuji, H., Venditti, F. J., Manders, E. S., Evans, J. C., Larson, M. G., Feldman, C. L., & Levy, D. (1994) · Circulation · doi:10.1161/01.cir.90.2.878 · Cited by 1,114
Reciprocal regulation of the neural and innate immune systems
Irwin, M. R., & Cole, S. W. (2011) · Nature Reviews Immunology · doi:10.1038/nri3042 · Cited by 910 · cited 1×
“In general, activation of the sympathetic branch of the ANS leads to increased inflammation and activation of the parasympathetic branch leads to decreased inflammation (Thayer and Sternberg, 2006; Irwin and Cole, 2011), although these effects are complex and highly contextual (Sanders and Straub, 2002).”
BackgroundHoward-Anderson, J., Ganz, P. A., Bower, J. E., & Stanton, A. L. (2012) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djr541 · Cited by 830 · cited 2×
“This group was of interest because they are at elevated risk for fatigue and other negative consequences of cancer treatment (Howard-Anderson et al., 2012).”
BackgroundSelf-citationHeart rate variability in depressive and anxiety disorders
Gorman, J. M., & Sloan, R. P. (2000) · American Heart Journal · doi:10.1067/mhj.2000.109981 · Cited by 510
Hann (1998) · Quality of Life Research · doi:10.1023/a:1008842517972 · Cited by 500
Fatigue in cancer patients during and after treatment
Servaes, P., Verhagen, C., & Bleijenberg, G. (2002) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00332-x · Cited by 498 · cited 1×
“Cancerrelated fatigue is experienced by 30—60% of patients undergoing cancer treatment (Jacobsen et al., 1999; Servaes et al., 2002; Lawrence et al., 2004; Bower, 2008), and can persist for up to ten years post treatment (Bower et al.”
BackgroundBrown, J. C., Huedo-Medina, T. B., Pescatello, L. S., Pescatello, S. M., Ferrer, R. A., & Johnson, B. T. (2011) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-10-0988 · Cited by 404
Groenvold, M., Petersen, M. A., Idler, E., Bjorner, J. B., Fayers, P. M., & Mouridsen, H. T. (2007) · Breast Cancer Research and Treatment · doi:10.1007/s10549-006-9447-x · Cited by 355 · cited 1×
“Cancer-related fatigue negatively impacts quality of life, and may predict shorter survival (Andrykowski et al., 1998; Bower et al., 2000; Groenvold et al., 2007).”
BackgroundNorepinephrine, the β-Adrenergic Receptor, and Immunity
Sanders, V. M., & Straub, R. H. (2002) · Brain, Behavior, and Immunity · doi:10.1006/brbi.2001.0639 · Cited by 272
RR Interval Variability Is Inversely Related to Inflammatory Markers: The CARDIA Study
Sloan, R. P., McCreath, H., Tracey, K. J., Sidney, S., Liu, K., & Seeman, T. (2007) · Molecular Medicine · doi:10.2119/2006-00112.sloan · Cited by 264 · cited 2×
“Low HRV is associated with elevated levels of circulating proinflammatory cytokines (Sajadieh et al., 2004; Sloan et al., 2007), and inflammation in turn is correlated with elevated symptoms of fatigue in cancer survivors (Bower and Lamkin, 2013).”
BackgroundReuben, D. B., Judd‐Hamilton, L., Harris, T. B., & Seeman, T. E. (2003) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2003.51380.x · Cited by 224
Gruenewald, T. L., Cohen, S., Matthews, K. A., Tracy, R., & Seeman, T. E. (2009) · Social Science & Medicine · doi:10.1016/j.socscimed.2009.05.018 · Cited by 188 · cited 1×
“The mean levels of RMSSD, HF-HRV, IL-6, and CRP, are comparable to those reported for healthy adults (Marsland et al., 2007; Gruenewald et al., 2009; Gordon et al., 2012).”
ResultStanton, A. L., Luecken, L. J., MacKinnon, D. P., & Thompson, E. H. (2013) · Journal of Consulting and Clinical Psychology · doi:10.1037/a0028833 · Cited by 114 · cited 1×
“Note that mediational effects may still be present when the relationship between the independent and dependent variable is weak (Stanton et al., 2013).”
BackgroundThe Fatigue Symptom Inventory: a systematic review of its psychometric properties
Donovan, K. A., & Jacobsen, P. B. (2011) · Supportive Care in Cancer · doi:10.1007/s00520-010-0989-4 · Cited by 94 · cited 2×
“94), which is above the clinically significant cutoff of 3 on this scale (Donovan and Jacobsen, 2010).”
BackgroundMethod
Cited by
An overview of heart rate variability metrics and norms
Shaffer, F., & Ginsberg, J. P. (2017) · Frontiers in Public Health · doi:10.3389/fpubh.2017.00258 · Cited by 7,185
Cancer-related fatigue—mechanisms, risk factors, and treatments
Bower, J. E. (2014) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2014.127 · Cited by 1,666
Self-citationAbrahams, H. J. G., Gielissen, M. F. M., Schmits, I. C., Verhagen, C. A. H. H. V. M., Rovers, M. M., & Knoop, H. (2016) · Annals of Oncology · doi:10.1093/annonc/mdw099 · Cited by 383
Heart rate variability and inflammation: A meta-analysis of human studies
Williams, D. P., Koenig, J., Carnevali, L., Sgoifo, A., Jarczok, M. N., Sternberg, E. M., & Thayer, J. F. (2019) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2019.03.009 · Cited by 358
Dieli-Conwright, C. M., Courneya, K. S., Demark-Wahnefried, W., Sami, N., Lee, K., Sweeney, F. C., Stewart, C., Buchanan, T. A., Spicer, D., Tripathy, D., et al. (2018) · Breast Cancer Research · doi:10.1186/s13058-018-1051-6 · Cited by 315
Metadata
- Authors
- Crosswell, A. D., Lockwood, K. G., Ganz, P. A., & Bower, J. E.
- Venue
- Psychoneuroendocrinology
- Publisher
- Elsevier BV
- Published
- 2014-07
- Volume
- 45
- Pages
- 58-66
- ISSN
- 0306-4530 (ISSN-L)
- OpenAlex
- W2057418424
- Cited by
- 137
- References
- 23
- FWCI
- 3.02
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.